FMR1N Polyclonal Antibody

Contains 1 P-type (trefoil) domain.,tissue specificity:Testis-specific. Expressed in melanoma, sarcoma, lung, breast, bladder, esophageal and ovarian cancers.,

The FMR1N Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of the Fragile X Mental Retardation 1 (FMR1) protein. This antibody is produced using a polyclonal approach, ensuring a diverse range of antibodies that target different epitopes of the FMR1 protein.

The FMR1N Polyclonal Antibody exhibits exceptional sensitivity and specificity, making it an ideal choice for various applications, including Western blotting, immunohistochemistry, and immunofluorescence. It has been extensively validated and proven to provide accurate and reproducible results in these experimental techniques.

This antibody is manufactured using state-of-the-art techniques and undergoes rigorous quality control measures to ensure its performance and reliability. It is produced in a host species that minimizes cross-reactivity, further enhancing its specificity.

The FMR1N Polyclonal Antibody is supplied as a liquid formulation, allowing for easy and convenient handling. It is provided in a range of sizes to accommodate different experimental needs. The antibody is stored in a stable formulation, ensuring long-term storage without compromising its performance.

With its exceptional specificity, sensitivity, and reliability, the FMR1N Polyclonal Antibody is an indispensable tool for researchers studying the FMR1 protein and its implications in Fragile X Mental Retardation.